Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis

Figure 5 Ferric reduced ability of plasma level in the colon. Values are mean ± SEM. Significantly different from sham group at ^aP < 0.05; Significantly different from sham group at ^bP < 0.01; Significantly different from sham group at ^bP < 0.001; Significantly different from control group at ^cP < 0.05; Significantly different from control group at ^dP < 0.01; Significantly different from control group at ^dP < 0.001; Significantly different from Dexa group at ^eP < 0.05; Significantly different from Dexa group at ^fP < 0.01; Significantly different from Dexa group at ^fP < 0.001; Significantly different from butyrate group at ^gP < 0.05; Significantly different from butyrate group at ^hP < 0.01; Significantly different from butyrate group at ^hP < 0.001; Significantly different from L-carnitine group at ⁱP < 0.05; Significantly different from L-carnitine group at ^jP < 0.01; Significantly different from L-carnitine group at ^jP < 0.001; Significantly different from L. casei group at ^kP < 0.05; Significantly different from L. casei group at ^lP < 0.01; Significantly different from L. casei group at ^lP < 0.001.